ResearcherGerman Cancer Research CenterActive in the last 2 years
Sarah Cronjaeger
Matched on ORCID iD 0009-0003-2794-4917; OpenAlex author ID A5120577896. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2026: 4 papers
Papers 4
- The rationale for targeting nectin-4 in pancreatic cancer. Co-author DOI 10.1016/j.trecan.2026.01.008↗
- Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer. Co-author DOI 10.1172/jci.insight.194290↗
- Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pancreatic Cancer Surgery. Co-author DOI 10.1245/s10434-026-19628-8↗
- ASO Visual Abstract: Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pancreatic Cancer Sur… Co-author DOI 10.1245/s10434-026-19708-9↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Adrian M. Seifert · 4 shared papers, 2026 · strength 1.24
- Paper The rationale for targeting nectin-4 in pancreatic cancer. DOI 10.1016/j.trecan.2026.01.008↗
- Paper Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pa… DOI 10.1245/s10434-026-19628-8↗
- Paper ASO Visual Abstract: Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific C… DOI 10.1245/s10434-026-19708-9↗
- Lena Seifert · 4 shared papers, 2026 · strength 1.24
- Paper The rationale for targeting nectin-4 in pancreatic cancer. DOI 10.1016/j.trecan.2026.01.008↗
- Paper Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pa… DOI 10.1245/s10434-026-19628-8↗
- Paper ASO Visual Abstract: Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific C… DOI 10.1245/s10434-026-19708-9↗
- David Digomann · 3 shared papers, 2026 · strength 0.74
- Paper Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pa… DOI 10.1245/s10434-026-19628-8↗
- Paper ASO Visual Abstract: Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific C… DOI 10.1245/s10434-026-19708-9↗
- Paper Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer. DOI 10.1172/jci.insight.194290↗
- Loreen Natusch Bufe · 3 shared papers, 2026 · strength 0.74
- Paper Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pa… DOI 10.1245/s10434-026-19628-8↗
- Paper ASO Visual Abstract: Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific C… DOI 10.1245/s10434-026-19708-9↗
- Paper Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer. DOI 10.1172/jci.insight.194290↗
- Jürgen Weitz · 3 shared papers, 2026 · strength 0.74
- Paper Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pa… DOI 10.1245/s10434-026-19628-8↗
- Paper ASO Visual Abstract: Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific C… DOI 10.1245/s10434-026-19708-9↗
- Paper Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer. DOI 10.1172/jci.insight.194290↗
- Michael B. Ghadimi · 2 shared papers, 2026 · strength 0.50
- Paper Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pa… DOI 10.1245/s10434-026-19628-8↗
- Paper ASO Visual Abstract: Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific C… DOI 10.1245/s10434-026-19708-9↗
- Sebastian Hempel · 2 shared papers, 2026 · strength 0.50
- Paper Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pa… DOI 10.1245/s10434-026-19628-8↗
- Paper ASO Visual Abstract: Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific C… DOI 10.1245/s10434-026-19708-9↗
- Florian Oehme · 2 shared papers, 2026 · strength 0.50
- Paper Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pa… DOI 10.1245/s10434-026-19628-8↗
- Paper ASO Visual Abstract: Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific C… DOI 10.1245/s10434-026-19708-9↗
- Franziska Baenke · 1 shared paper, 2026 · strength 0.24
- Max Heiduk · 1 shared paper, 2026 · strength 0.24
- Daniel E. Stange · 1 shared paper, 2026 · strength 0.24
- Diane M. Simeone · 1 shared paper, 2026 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.